Gladstone Institutional Advisory’s Ligand Pharmaceuticals LGND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q1
Sell
-6,838
Closed -$424K 431
2020
Q4
$424K Buy
+6,838
New +$424K 0.08% 178